1. Home
  2. JVA vs AWH Comparison

JVA vs AWH Comparison

Compare JVA & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JVA
  • AWH
  • Stock Information
  • Founded
  • JVA 1971
  • AWH 1993
  • Country
  • JVA United States
  • AWH United States
  • Employees
  • JVA N/A
  • AWH N/A
  • Industry
  • JVA Packaged Foods
  • AWH Medical/Dental Instruments
  • Sector
  • JVA Consumer Staples
  • AWH Health Care
  • Exchange
  • JVA Nasdaq
  • AWH Nasdaq
  • Market Cap
  • JVA N/A
  • AWH 12.8M
  • IPO Year
  • JVA 2005
  • AWH N/A
  • Fundamental
  • Price
  • JVA $3.70
  • AWH $0.72
  • Analyst Decision
  • JVA
  • AWH Buy
  • Analyst Count
  • JVA 0
  • AWH 2
  • Target Price
  • JVA N/A
  • AWH $4.40
  • AVG Volume (30 Days)
  • JVA 155.0K
  • AWH 76.6K
  • Earning Date
  • JVA 02-07-2025
  • AWH 11-14-2024
  • Dividend Yield
  • JVA N/A
  • AWH N/A
  • EPS Growth
  • JVA N/A
  • AWH N/A
  • EPS
  • JVA 0.20
  • AWH N/A
  • Revenue
  • JVA $76,111,698.00
  • AWH $8,963,000.00
  • Revenue This Year
  • JVA N/A
  • AWH $11.87
  • Revenue Next Year
  • JVA N/A
  • AWH $79.10
  • P/E Ratio
  • JVA $19.50
  • AWH N/A
  • Revenue Growth
  • JVA 17.27
  • AWH N/A
  • 52 Week Low
  • JVA $0.85
  • AWH $0.67
  • 52 Week High
  • JVA $4.66
  • AWH $5.65
  • Technical
  • Relative Strength Index (RSI)
  • JVA 47.93
  • AWH 43.92
  • Support Level
  • JVA $3.40
  • AWH $0.71
  • Resistance Level
  • JVA $4.01
  • AWH $0.81
  • Average True Range (ATR)
  • JVA 0.32
  • AWH 0.07
  • MACD
  • JVA -0.06
  • AWH 0.00
  • Stochastic Oscillator
  • JVA 23.81
  • AWH 37.06

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Share on Social Networks: